I mplant therapy is today widely regarded as a reliable treatment option to replace missing teeth, both for function and esthetics, as documented by recent 10-year studies conducted with current implant systems. [1] [2] [3] [4] [5] [6] [7] The original treatment protocols of the 1970s and 1980s required fully healed alveolar ridges before implants were placed. 8, 9 In the 1990s, these protocols were modified to include implant placement in fresh extraction sockets 10, 11 or in partially healed alveolar ridges 12 predominantly for implants in the esthetic zone.
At a consensus conference of the International Team for Implantology (ITI) in 2003, Belser et al concluded that although the use of dental implants in the esthetic zone was well documented, there was a lack of well-defined esthetic parameters to evaluate outcomes. 13 At the same conference, a classification system for the timing of implant placement after tooth extraction was developed, which was based on morphologic, histologic, and dimensional changes of the alveolar ridge. 14 The systematic review that formed the basis of this classification concluded that the evidence for esthetic outcomes in postextraction sites was insufficient for definitive conclusions to be drawn. 15 Postextraction implant placement in this context refers to immediate placement (type 1), early placement with soft tissue healing (type 2), early placement with partial bone healing (type 3), and late placement (type 4).
In the 10-year period since this consensus conference, there has been an increase in the reporting of esthetic parameters including changes in the position of the peri-implant mucosa 16 and esthetic indices based on ordinal scales. 17 Esthetic indices have provided clinicians and researchers with more objective tools to evaluate hard and soft tissue-related esthetic outcomes with implant-supported prostheses.
During the same period, it was recognized that the resorption and modeling of the alveolar ridge in postextraction sites has the potential to influence esthetic results. 18 The use of bone augmentation procedures using biomaterials with a low substitution rate has been proposed as a means to reduce these postextraction dimensional changes. 19 Technological advances in three-dimensional (3D) radiology have provided researchers with a noninvasive method to evaluate these bone augmentation procedures in relation to postextraction implants. 20, 21 The objectives of this systematic review are (1) to quantitatively estimate the esthetic outcomes of implants placed in postextraction sites, and (2) to evaluate the influence of simultaneous bone augmentation procedures on these outcomes.
MATERIALS AND METHODS

Search Strategy
The reporting of this systematic review is based on the PRISMA guidelines (http://www.prisma-statement. org). An electronic search of the literature was performed according to the criteria set out in Table 1 .
Selection of Studies
Screening of the titles and selection of abstracts for potential inclusion in the review was undertaken independently by the two reviewers. The full texts of the shortlisted abstracts were reviewed independently, and articles for inclusion were selected on the basis of the criteria stipulated in Table 1 . Any disagreement was resolved by discussion between the reviewers. The Kappa value for interassessor agreement during screening of title and abstract was 0.92 and 0.88 respectively, indicating excellent agreement.
Excluded Studies
Out of the 117 full-text articles assessed, 67 were excluded from the final analysis due to the following reasons:
• Review papers or papers of methodology • Data for the same population duplicated in another study • Insufficient data/lack of esthetic parameters to assess esthetic outcomes • Unable to separate data for different placement time • Unable to separate data for sites in the anterior maxilla (esthetic zone defined as the maxillary anterior and maxillary premolar teeth) from posterior and mandibular sites • Data available only for implant placement in healed sites • Case reports with less than 5 cases
Quality Assessment
Randomized controlled trials (RCTs) and cohort studies were assessed for bias using the Cochrane Collaboration tool, which consisted of six domains that addressed the adequacy of sequence generation, allocation concealment, blinding of participants, handling of incomplete outcome data, steps to minimize selective outcome reporting, and whether other sources of bias were identified (http://ohg.cochrane. org/sites/ohg.cochrane.org/files/uploads/Risk%20 of%20bias%20assessment%20tool.pdf ). According to the Cochrane Collaboration tool, a judgment of "risk of bias" was assigned if one or more key domains had a high risk of bias. Cohort studies were assessed for quality and reporting using the Newcastle-Ottawa scale, which provides for eight key domains (http://www. ohri.ca/programs/clinical_epidemiology/oxford.asp). One star is awarded for each domain in which the criteria are fulfilled, with the exception of "comparability" which can be awarded two stars. A maximum of nine stars may be assigned to a study.
Data Extraction
From the included articles, data on timing of implant placement postextraction, simultaneous placement of bone grafts, connection of provisional crowns immediately after implant placement, peri-implant soft tissue dimensional changes, and esthetic indices were extracted and recorded on standardized forms. In addition, inclusion and exclusion criteria were recorded. Any disagreement between reviewers was resolved by discussion.
Statistical Analysis
A preliminary analysis of the included studies showed that the majority of studies were case series studies. There were insufficient RCTs of similar design to permit a meta-analysis. Of the non-randomized studies (cohort, cross-sectional, and case series), it was noted that there was significant heterogeneity in study design, study population, follow-up times, and esthetic parameters reported. Therefore, descriptive methods were mainly used to present the data.
For non-randomized studies, a trend analysis was undertaken. Studies were included for this analysis if the subjects were consecutively enrolled, there was no deviation in the treatment protocol, and the follow-up period was between 1 and 3 years. Studies were grouped according to methodologic similarities based on timing of implant placement postextraction, use of bone graft, use of connective tissue (CT) graft, and use of immediate provisional crowns. The data were presented in forest plots with weights derived from random-effect analysis (Comprehensive Meta Analysis v2.2.064). Data from randomized studies were not included in this part of the analysis (http://handbook. cochrane.org/chapter_13/13_including_non_random-ized_studies.htm). Overall effects were not calculated due to the high risk of bias with case series studies and significant heterogeneity. Statistical homogeneity was determined using Cochran Q and its associated P value, and the I-squared statistic. Clinical implications of data heterogeneity were reviewed when the P value was less than 0.1, and the I-squared statistic became increasingly higher. The random-effects model was used to weight studies on the forest plots. All data are presented in mm as means ± standard deviations. 
RESULTS
Following the systematic search strategy (Fig 1) , a total of 50 studies were included in this systematic review of esthetic outcomes with postextraction implants (Table 2) . These 50 studies were comprised of 6 RCTs, [22] [23] [24] [25] [26] [27] 6 cohort studies, 28-33 5 cross-sectional studies, [34] [35] [36] [37] [38] and 33 case series studies. 20, 21, There were 7 studies. 21, 33, 38, 58, 60, 61, 69 that were identified as followup reports of previous publications. 35, 40, [45] [46] [47] 54, 55 One paper 36 presented data on esthetic outcomes on the patient pool of a previous paper. 35 Data were extracted from the more recent publications and tabulated. Any missing data were obtained from the earlier publications. The list of excluded studies, 45, including reasons for exclusion may be found in Table 3 .
Of the six included RCTs, four were judged to be at risk of bias mainly due to nonconcealment and nonblinding of the examiners (Table 4) . 22, 23, 25, 26 The majority of the included cohort studies were of sufficient quality (Table 5) . 28, 29, 32, 33 For the case series studies, the majority were prospective in design with consecutively enrolled subjects. All the included studies assessed outcomes following placement of singletooth implants in postextraction sites adjacent to natural teeth.
Change in Position of the Peri-implant Mucosa
Study Characteristics. There were 5 RCTs, 22-26 5 cohort studies, [28] [29] [30] [31] 33 3 cross-sectional studies, 21, 34, 37 and 25 case series studies 20, 21, 30, [39] [40] [41] 44, 46, [48] [49] [50] [51] [52] [53] [56] [57] [58] [59] [60] [61] [62] [65] [66] [67] [68] [69] [70] [71] [72] 92 that provided data on change in position of the periimplant mucosa following implant placement. The majority of studies were prospectively designed, with only two studies identified as retrospective reports. 20, 53 The data are summarized in Table 6 for studies with comparative data (RCT and cohort studies) and Table 7 for cross-sectional and case series studies.
Study Duration.
For studies with comparative data, four studies provided short-term data with observation periods of 6 31 and 12 months. 22, 24, 29 Three studies reported on 2-year outcomes 23, 25, 37 and one study provided 3-year data. 26 One study reported on outcomes after a follow-up period of 5 years. 28 Most of the case series were short-term, with a follow-up period of 12 months reported in 13 studies, 30, [39] [40] [41] [42] 46, 47, 56, 57, 59, 65, 67, 92 13 to 24 months in 7 studies 34, 44, [49] [50] [51] 53, 66 and 25 to 36 months in 6 studies. 36, 48, 52, 58, 60, 62 There was 1 study with an observation Randomized controlled studies (RCTs) 6 Lindeboom et al, 22 Palattella et al, 23 De Rouck et al, 24 Block et al, 25 Chen et al, 26 Felice et al 27 Cohort studies 6 Gotfredsen, 28 Cangini and Cornelini, 29 Juodzbalys and Wang, 30 Grunder, 31 Raes et al, 32 De Bruyn et al 33 Cross-sectional studies 5 Evans and Chen, 34 Buser et al, 35 Belser et al, 36 Miyamoto and Obama, 37 Cosyn et al 38 Case series studies 33 Grunder, 39 Kan et al, 40 Cornelini et al, 41 Juodzbalys and Wang, 42 Kan et al, 43 Canullo and Rasperini, 44 Noelken et al, 45 De Rouck et al, 46 Buser et al, 47 Kan et al, 48 Pirker and Kocher, 49 Redemagni et al, 50 Tortamano et al, 51 Chen et al 52 Cosyn and De Rouck, 53 Cooper et al, 54 Cosyn et al, 55 Brown and Payne, 56 Tsuda et al, 57 Buser et al, 58 Chung et al, 59 Cosyn et al, 60 Kan et al, 61 Malchiodi et al, 62 Mangano et al, 63 Noelken et al, 64 Benic et al, 20 Cabello et al, 65 Lee et al, 66 Buser et al, 21 Cosyn et al, 67 Furze et al, 68 Noelken et al 69 71 Den Hartog et al, 97 Grutter and Belser, 108 Freitas et al 111 Data for the same population reported in a later study 1 Raes et al 132 Insufficient data and/or lack of parameters to evaluate esthetic outcomes 9
Vanden Bogaerde et al, 84 Noelken et al, 45 Degidi et al, 96 Kollar et al, 99 Stein et al, 109 Juodzbalys and Wang, 113 Siebers et al, 114 Di Alberti et al, 129 Schwarz et al 131 Data for maxillary anterior sites could not be separated from posterior and mandibular sites 6 Bianchi and Sanfilippo, 76 Cordaro et al, 106 Schropp and Isadore, 104 van Kesteren et al, 117 De Angelis et al, 120 Covani et al 128 Data available only for implant placement in healed sites or sites that underwent ridge preservation prior to implant placement
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Van der Zee et al, 81 Hall et al, 91 Lindeboom et al, 87 Cannizzaro et al, 95 Meijndert et al, 102 Aldredge and Nejat, 118 Hof et al, 122 Tymstra et al, 116 Fu et al, 112 Lee et al, 124 Schneider et al 127 Case reports with less than 5 cases 2 Testori et al, 83 Levin 125 Total 64 23 Each group comprised eight patients and nine single-tooth implants in the maxillary anterior region. Recession of the midfacial mucosa occurred in both groups without statistically significant difference between the groups after 2 years (type I group, -0.8 ± 0.7 mm vs type 2 group, -0.6 ± 0.6 mm; P > .05).
In a RCT that compared type 1 and type 3 implant placement at single-tooth sites with radiographic evidence of chronic periapical lesions, no difference in the level of the midfacial mucosa was observed between the two placement protocols. 22 The frequency of mucosal recession, however, was slightly greater in type 1 placement sites (0 to 1 mm in 7 of 23 sites; 1 to 2 mm in 2 of 23 sites) compared to type 3 placement sites (0 to 1 mm in 4 of 25 sites; 1 to 2 mm in 0 of 25 sites).
Immediate versus delayed restoration of immediately placed implants was compared in a RCT which combined implant placement and grafting of the periimplant defect with DBBM. 24 After 1 year, significantly less recession of the midfacial mucosa (P = .005) was observed in the immediate restoration group (25 implants in 25 patients; 1 early failure; -0.41 ± 0.75 mm) compared to the delayed restoration group (25 implants in 25 patients; -1.16 ± 0.66 mm). No differences were observed in recession of the mesial and distal papillae between the immediate restoration group and delayed restoration group (mesial papilla -0.41 ± 0.77 mm vs 0.43 ± 0.42 mm, respectively; distal papilla -0.31 ± 0.81 mm vs -0.53 ± 0.55 mm, respectively).
Three bone augmentation methods with type 1 implant placement were compared in a RCT. 26 A high proportion of sites across all three groups (10 of 30) demonstrated recession of the midfacial mucosa of greater than 1 mm. Implants placed buccally in the extraction sockets were significantly associated with recession.
Outcomes from Non-randomized Studies. Four cohort studies provided comparative data on timing of implant placement after extraction. 28, 30, 33, 37 In a prospective cohort study, 25 consecutively enrolled patients received implant placement after extraction according to a decision tree based on the morphology of the extraction socket. 30 Sockets that were considered adequate were treated by flapless type 1 implant placement with a non-submerged approach. Compromised sockets were treated with one of the following techniques: Flapless type 1 implant placement with a non-submerged approach, type 2 placement 6 weeks after tooth extraction with simultaneous soft and/or hard tissue augmentation, or type 1 implant placement with simultaneous soft and/or hard tissue augmentation. Deficient sockets were reconstructed with GBR and soft tissue grafting procedures prior to implants being placed. After 12 months, all "adequate" sockets achieved satisfactory esthetic outcomes. Compromised sockets treated with type 1 implant placement showed initially adequate esthetic results, but 50% were downgraded to compromised after 1 year. On the other hand, compromised sockets with type 2 placement showed better results, initially 87.5% satisfactory at prosthesis placement and 62.5% after 1 year.
Miyamoto and Obama in a retrospective cohort study reported significantly greater recession at the 2-year follow-up visit with type 1 placement compared to type 2 placement. 37 There were three treatment groups: type 1 placement combined with autogenous bone graft (5 patients and 7 implants), type 2 placement in which guided bone regeneration (GBR) was performed with nonresorbable membranes (8 patients and 16 implants), and type 2 placement combined with GBR using resorbable membranes (3 patients and 8 implants). The implants were conventionally loaded. Recession of the midfacial mucosa of 0.85 ± 0.79 mm, 0.06 ± 0.25 mm, and 0.50 ± 0.53 mm was observed for the three groups, respectively. The differences were significant between the type 1 placement group and the type 2 placement with nonresorbable membrane group (P < .05). Cone beam computed tomography (CBCT) data indicated that vertical resorption of the facial bone occurred, with dimensions of 3.25 ± 4.68 mm, 0.13 ± 0.36 mm, and 0.70 ± 1.02 mm recorded, respectively.
Gotfredsen compared outcomes between type 2 and type 3 implant placement in a prospective cohort study. 28 Single-tooth implants were placed in 10 patients 4 weeks after extraction (type 2 group) and 10 patients 12 weeks after extraction (type 3 group). After 5 years, the difference in crown length between implants and control teeth was 0.6 ± 0.7 mm in the type 2 placement group and 0.7 ± 1.4 mm in the type 3 placement group (no significant difference; P > .05). Recession of the papillae 0.3 ± 0.5 mm and 1.0 ± 0.7 mm occurred in the type 2 and type 3 placement groups, respectively. Type 1 and type 4 implant placement were compared in a prospective cohort study. 33 In the type 1 placement group, 55 patients received 55 single-tooth implants. In the type 4 placement group, 58 patients received 58 single-tooth implants. All implants had provisional crowns with no occlusal contacts connected immediately after placement. In the type 1 placement group, two early failures (3.6%) were recorded and one patient was lost to follow-up. In the type 4 placement group, one early failure (1.7%) was noted. A slight positive change in the mucosal level was observed from final crown placement to the 3-year recall in both type 1 and type 4 placement groups (0.23 ± 0.87 mm vs 0.27 ± 1.03 mm). Similarly, a slight gain in papilla height (mesial and distal papillae combined) was observed between final crown insertions to the three-year recall in both groups (0.29 ± 1.08 mm vs 0.53 ± .07 mm, respectively). The difference between groups for midfacial mucosa and papillae were not significant. In a RCT comprising 55 implants and 55 patients, type 1 placement (26 patients) was compared to placement in sites that had undergone ridge preservation (29 patients) using demineralized freeze-dried bone allograft. 25 Implants were immediately restored with provisional crowns. After 2 years, the lengths of the implant crowns were significantly longer in the ridge preservation group (8.6 ± 2.6 mm) compared to the type 1 placement group (7.4 ± 2.4 mm).
In a prospective cohort study, enamel matrix derivative (EMD) was compared to resorbable collagen membrane in conjunction with type 1 implant placement. 29 Significantly less recession of the midfacial mucosa was observed in the EMD-treated sites compared to the membrane-treated sites.
The majority of the case series studies with data on dimensional changes of the peri-implant mucosa were reports on type 1 implant placement. Four studies reported on type 2 implant placement, two of which were follow-up reports on the same patient population. 21 The predominant finding was that recession of the midfacial mucosa and papillae occurred with postextraction implant placement. In most studies, the mean recession of the midfacial mucosa and tooth-implant papillae was less than 1 mm. 39,41,46,48,49,53,56--59,62,65,67 There were five studies that reported no change 50 or a gain in mucosal height. 44, 48, 51, 66 Four of these studies were of type 1 placement using a flapless approach and immediate provisional prosthesis, 44, 51 as well as incorporation of a connective tissue graft at the same time. 48, 50 One study combined CT graft and coronal flap advancement to correct preexisting gingival recession at sites in which the extracted teeth were periodontally compromised. 66 A significant mean gain of 2.1 ± 0.7 mm of the midfacial mucosa was reported in this study.
Non-randomized studies that fulfilled the criteria of consecutively enrolled patients, nondeviation of the treatment protocol, and follow-up time of 1 to 3 years were analyzed for trends in outcomes. 34, 35, [39] [40] [41] 44, 48, 51, 53, [56] [57] [58] [59] [60] 62, 65 Studies were grouped according to placement timing (Fig 2) . A greater variation in results was noted for type 1 placement (13 studies; I-squared = 89.783, P = .000) compared to type 2 placement (3 studies; I-squared = 66.103, P = .062). These studies varied in surgical protocol (flap vs flapless elevation), hard and soft tissue grafting, and loading protocols. Further stratification of studies on type 1 placement was made according to treatment methodology (use of bone graft, flapless surgery, provisional crown, and CT graft) (Fig 3) . From the forest plots, less variation in results was seen for the combination on bone graft, flapless surgery, provisional crown, and CT graft at the time of type 1 implant placement (3 studies; I-squared = 33.74, P = .223).
There was one study of type 2 implant placement 53 and eight studies of type 1 implant placement 34, 39, 40, 44, 51, 53, 60, 62, 65 that provided data on change in position of the mesial and distal papillae (Fig 4) . Significant heterogeneity between studies was noted which generally indicated that recession of the papillae occurred with both placement timings. Grouping of type 1 placement studies according to use of provisional crown and surgical approach (flap versus flapless surgery) revealed a homogeneity between two studies 34, 39 in which implants were placed with conventional flap surgery and no provisional crowns connected immediately (mesial papilla: I-squared = 0.000, P = .999; distal papilla: I-squared = 51.089, P = .153) (Fig 5) . Examination of the forest plots yielded no distinct trend in change of papilla position based on surgical approach and use of immediate provisional crowns.
Frequency of Recession. In addition to reporting mean values, several studies also reported on the frequency of recession of the midfacial mucosa. In a RCT, Lindaboom and coworkers reported a higher frequency of recession at the type 1 placement group (0 to 1 mm in 7 of 25 sites and 1 to 2 mm in 2 of 25 sites) compared to type 3 placement group (0 to 1 mm in 4 of 25 sites and 1 of 2 mm in 0 to 25 sites) when compared to the adjacent control teeth. 22 In another RCT, 10 of 30 sites exhibited recession of the midfacial mucosa of 1 to 3 mm following type 1 implant placement and transmucosal healing. 26 In two studies of type 1 placement using a conventional surgical approach and conventional loading protocol, the frequency of recession of the midfacial mucosa of 1 mm or more was reported to be 21.4% 42 and 40.5%. 34 Two studies of type 1 placement with immediate provisional restoration of the implants reported on the frequency of recession of the midfacial mucosa. In one study, implants were placed in extraction sites with thick tissue biotype using a minimal flap elevation. Recession of the midfacial mucosa of 1 mm or more was noted in 9% of sites within 3 months of the implants being placed. 67 In the other study, implants were placed with a flapless surgical technique. After 3 years, recession of the midfacial mucosa of 1 mm or more was observed in 31.3% of sites. 62 In contrast, one study of type 2 implant placement using conventional flap elevation, GBR with autogenous bone chips and DBBM and a submerged healing protocol reported 1 out of 20 sites with recession (0.5 to 1 mm) after 3 years. 58 In a study of type 1 placement in the presence of defects in the facial bone of varying size, recession of the midfacial mucosa of 1.5 mm or more was reported in 34.8% of sites. 92 The defects were grafted with autogenous bone chips or DBBM combined with a resorbable collagen membrane. In the presence of thin periodontal tissue biotype, additional grafting with CT was carried out. The implants were provisionally restored following placement. It was noted that the frequency of recession increased with correspondingly larger defects in the facial bone.
In contrast, one study of type 2 placement reported a relatively low incidence of recession of the midfacial mucosa. 58 Type 2 implant placement was combined with GBR using autogenous bone chips and DBBM and resorbable collagen membrane. After 3 years, 1 of 20 sites (5%) demonstrated recession, which was in the range of 0.5 to 1 mm.
Outcomes from CBCT. Three studies provided data on CBCT reconstructed images of the bone on the facial aspect of maxillary anterior implants. In the study of Miyamoto and Obama, type 1 placement sites were grafted with autogenous bone to fill the peri-implant defect. Type 2 placement sites were grafted with DBBM and either a resorbable or nonresorbable barrier membrane. 37 Significantly greater recession of the midfacial mucosa occurred at type 1 placement sites compared to type 2 placement sites after a mean of 28 months (SD, 15.8 months). There was correspondingly greater vertical crestal bone 21 Out of the original 45 patients who received single-tooth implants combined with GBR using autogenous bone chips, DBBM and resorbable collagen membrane and were examined in 2006, 35 41 were able to be recalled 4 years later in 2010 (5 to 9 years after implant placement). 21 Clinical data were recorded and CBCT scans were obtained. There was no change in the length of the implant crowns between the 2 time points (9.48 ± 1.09 mm at the first examination and 9.47 ± 1.22 mm at the second examination). From reformatted CBCT images, the orofacial thickness of the facial bone wall was measured at three levels. At 2 mm from the implant shoulder, the mean orofacial thickness was 1.58 ± 1.00 mm. The corresponding measurements at 4 mm and 6 mm levels were 2.2 ± 0.98 mm and 2.33 ± 1.14 mm, respectively. In 2 of 41 implants (4.9%), no facial bone wall was detectable radiographically.
Factors Associated with Risk for Recession. From the included studies, factors associated with risk for recession of the midfacial mucosa were identified as pre-existing defects of the facial bone, tissue biotype, implant malposition, stability, and thickness of the facial bone and biomaterials used.
The influence of pre-existing defects in the facial bone on recession of the midfacial mucosa was identified in a study of type 1 placement. 43 In this study, all extraction sites presented with varying degrees of damage to the facial socket wall. Following implant placement, the defects were grafted with autogenous bone or DBBM combined with a resorbable collagen membrane. In the presence of thin periodontal tissue biotype, additional grafting with CT was carried out in 11 of 23 (47.8%) sites. The implants were provisionally restored immediately following implant placement. After 1 year, recession of the facial mucosa of 1.5 mm or more was observed in 34.8% of sites. At sites with minor defects in the facial bone, 8.3% of sites developed recession. At sites with larger defects, 42.8% of sites demonstrated recession of the mucosa. In extraction sites with a complete loss of the facial bone wall, recession of the mucosa occurred in 100% of sites. Thin tissue biotype was identified as a risk factor for mucosal recession. In a study of type 1 implant placement using a flapless surgical approach and immediate provisional restoration, thin biotype sites had significantly more recession than thick biotype sites after 1 year (0.75 ± 0.59 mm vs 0.25 ± 0.33 mm, respectively). In a retrospective study of type 1 placement using a conventional surgical approach and loading protocol, a higher frequency of recession of the midfacial mucosa of 1 mm or more was observed for thin biotype sites (11 of 24 sites) compared to thick biotype sites (6 of 18). 34 Of the sites that developed recession, 6 of the 11 thin biotype sites showed severe recession of more than 2 mm. In contrast to these observations, Kan et al reported no differences between thick and thin tissue biotype sites when CT grafts were incorporated in the surgical protocol of flapless implant placement and immediate restoration. 48 Two studies reported that the position of the implant in the extraction socket at type 1 placement sites was an important risk factor for mucosal recession. 26, 34 Implants that were malpositioned facially in the extraction sockets were significantly associated with an increased risk for mucosal recession. 2 Recession of the mucosa was three times greater in facially malpositioned implants (1.8 ± 0.83 mm) compared to implants placed more orally in the socket (0.6 ± 0.55 mm); the difference was statistically significant. 34 Based on the studies with CBCT data, type 1 implant placement was associated with significant vertical resorption of the crestal bone and recession of the midfacial mucosa irrespective of the grafting material used (autogenous bone versus DBBM). 20,37 A significant proportion of type 1 placement sites did not have a detectable bone wall on the facial aspect of the implants. 20 In contrast, type 2 placement sites grafted with autogenous bone chips and/or DBBM were associated with less recession of the mucosa 21, 37 and a much higher proportion of sites retained detectable bone on the facial aspect of the implants after 7 years. 21 Mucosal Stability. Several studies of type 1 implant placement reported that the greatest dimensional change took place within the first 3 months of surgery. 24, 26, 46, 65, 67 In two studies, mucosal recession was severe enough to require intervention with CT grafts. 26, 67 In the study of Chen et al, recession of the midfacial mucosa of 1 to 3 mm occurred in 10 of 30 sites within the first 12 months of surgery. Several sites required corrective treatment using CT grafts. 26 Cosyn and coworkers reported that with type 1 placement combined with immediate provisional restoration and grafting of the peri-implant defect with DBBM, 9% of sites had recession of 1 mm or more within 3 months of implant placement. 67 Severe recession of 1.5 to 2 mm was noted in two patients. Overall, seven patients (seven implants or 31.8% of cases) required adjunctive CT grafts to correct the recession of the midfacial mucosa.
Between 1 to 3 years, the mucosa was reported to be stable in two studies. 26, 33 In contrast, Kan and co-workers reported that after initial recession of the peri-implant mucosa, ongoing changes took place between the first examination at 1 year and the followup of examination that took place 2 to 8.2 years later (mean 4 years). 61 Patients had received type 1 placement implants with connection of immediate provisional restorations. Bone grafts were not placed. At 1 year, mean recession of the midfacial mucosa was 0.53 ± 0.23 mm. Recession at the follow-up examination had increased to 1.13 ± 0.87 mm. There was a corresponding increase in the recession of the tooth-implant papillae. Thin biotype sites receded three times more than thick biotype sites. Four patients (11%) expressed concern about the mucosal recession, and three underwent hard and soft tissue grafting procedures to repair the recession. Studies of type 2 placement showed stable mucosal conditions after 3 years 58 and after an average of 7 years in another study from the same group. 21 In both studies, GBR using autogenous bone chips, DBBM, and resorbable collagen membrane was performed. Gotfredsen and coworkers observed stable peri-implant mucosal conditions following type 2 and type 3 implant placement after 5 years. 28 Non-resorbable e-PTFE membranes were used for bone augmentation in this study.
Outcomes Based on Esthetic Indices
Study characteristics. One RCT, 27 one cohort study, 32 one cross-sectional study, 38 and 13 case series studies 21, 36, 42, 47, 52, 55, 58, 60, 63, 64, [67] [68] [69] reported on esthetic outcomes based on esthetic indices (Tables 8 and 9 ). Three studies 21, 38, 58 were follow up reports of previous studies. 36, 47, 55 All papers were recent publications, the majority having been published since 2009. The majority of studies that fulfilled the inclusion criteria for this systematic review reported on outcomes using the Pink Esthetic Score (PES) in which scores of 0,1, and 2 are assigned to seven soft tissue esthetic parameters to reach a maximum score of 14. 21, 27, 32, 36, 38, 42, 47, 52, 58, 60, 63, 64, [67] [68] [69] In five of the studies, a modified version of the PES was used, in which scores of 0, 1, and 2 are assigned to five soft tissue esthetic parameters to reach a maximum score of 10. 21, 36, 58, 63, 68 The authors of two of the studies, when contacted, provided the full PES. 58, 63 The White Esthetic Score (WES), which assigns scores of 0, 1, and 2 to 5 prosthesis-related parameters (to reach a maximum score of 10) was reported in five studies. 21, 58, 60, 67, 68 The Subjective Esthetic Score (SES), which ranks soft tissue related outcomes according to the degree of mucosal recession and volume of the soft tissues on a categorical scale of 1 to 4, was reported in two papers. 34, 52 Outcomes from Randomized Studies. One RCT reported on outcomes using an esthetic index. In this study, type 1 placement with DBBM graft was compared to implant placement in sites that had been grafted with DBBM 4 months previously (ridge preservation group). 27 Provisional restorations were connected to the implants in both groups immediately following their placement. There were 54 patients in the type 1 placement group and 52 patients in the ridge preservation group. Short-term data at 4 months from the time of provisional prosthesis insertion were reported. The authors reported that 35% and 75% of implants in the type 1 placement and ridge preservation groups respectively did not have the provisional restorations connected immediately due to lack of sufficient implant stability. The PES for the type 1 placement and ridge preservation groups were 12.75 ± 0.25 and 12.62 ± 1.05, respectively, with no significant difference between groups.
Outcomes from Non-randomized Studies. In a cohort study that involved single-tooth implants with immediate provisional restorations, type 1 placement was compared to type 4 placement after 1 year. No bone grafts were placed at the time of implant insertion. After 1 year, the PES was 10.33 ± 2.04 for the type 1 placement group and 10.35 ± 1.58 for the type 4 group. The difference was not significantly different. The WES was similar between the type 1 placement (WES 7.20 ± 2.04) and type 4 placement (WES 7.00 ± 2.37) groups.
In a cross-sectional study in which patients were examined on average 33 months from the time of implant placement, 4 treatment modalities were identified in relation to timing of implant placement. 38 For type 1 placement, DBBM was grafted to the gap between the implant and socket wall (28 patients and 30 implants). There were two treatment modalities for type 2 placements-49 implants in the 44 patients were placed without augmentation procedures and at 19 implants in 18 patients, GBR using DBBM and resorbable collagen membrane was used. A staged bone graft and late placement group was also identified, in which block bone grafts had been placed to augment deficient sites prior to implant insertion (14 implants in 14 patients). At type 1 placement sites, all cases had thick gingival biotype, intact facial bone, and ideal soft tissue levels. For the type 2 without GBR group, a minimum of 1.5 mm of bone thickness was present on the facial aspect of the implants. Both thin and thick tissue biotype cases were treated in this group. For the type 2 group with GBR, less than 1.5 mm of bone thickness was present on the facial aspect of the implant. Both thin and thick biotype cases were treated in this group. There were two early failures in the type 1 placement group, five in the type 2 placement group (three in the nongrafted group, and one in the GBR group) and one failure in the staged block graft group. Esthetic outcomes were assessed using PES. Similar results were achieved with type 1 and type 2 placements (type 1 group 10.88 ± 2.41, type 2 no GBR group 10.07 ± 1.96, type 2 with GBR group 9.65 ± 2.23). The worst esthetic outcomes were observed in the staged bone graft group (9.00 ± 1.73), the difference with the type 1 placement group approaching statistical significance (P = .045).
The overall esthetic outcomes reported in the case series studies were good, with average PES ranging from 10.48 to 12.5 in six studies 42, 52, 60, 64, 67, 69 and modified PES ranging from 7.0 to 8.1 in four studies. 21, 58, 63, 68 From selected studies, the forest plots showed no clear trend to indicate a difference between placement times (Fig 6) . Prosthesis related esthetic outcomes using WES was reported in five studies with mean scores ranging 7.0 to 8.65. 21, 58, 60, 67, 68 Ranking of Esthetic Outcomes. Several studies ( Table 8 ) presented data that allowed esthetic outcomes to be ranked according to the criteria proposed by Cosyn et al 60 and Belser et al. 36 There were two studies of type 1 placement that reported excellent soft tissue esthetic outcomes (PES 12 to 14) in 29% to 36% of cases. 30, 60 Acceptable outcomes (PES 8 to 11) were achieved in 56% to 71% of sites and poor outcomes (PES 0 to 7) were found in 8% of cases in one study. In two studies of type 2 placement using the modified PES, excellent esthetic outcomes (modPES 9 to 10) were achieved in 22% to 45% of sites, acceptable outcomes (modPES 6 to 8) in 50% to 78% of sites and poor outcomes (modPES < 6) in 1 of 20 cases (5%) in one study. 58 When PES and WES were considered together in determining esthetic outcomes, between 8% to 21% achieved excellent outcomes (PES ≥ 12, WES ≥ 9), 58% to 68% achieved acceptable outcomes (PES 8 to 11, WES 7 to 8), and 21% to 24% resulted in poor outcomes (PES < 8, WES < 6). 32, 60 These results suggest that prosthesis related factors may contribute significantly to poorer outcomes when soft tissue and hard tissue related esthetic parameters are combined.
In two reports of type 1 placement using SES to evaluate esthetic outcomes, about 80% of implants had satisfactory esthetic outcomes, whereas 20% were found to be unsatisfactory. 34, 52 Inclusion and Exclusion Criteria A number of systemic, oral, and site-related factors were listed as inclusion and exclusion criteria in the studies included in this review.
Systemic Factors. Medical conditions or medications that could compromise wound healing or osseointegration were common exclusion criteria. 22, [24] [25] [26] 33, 35, 38, 40, 47, 51, 56, 60, 62, 65, 67, 68 Conditions such as uncontrolled diabetes, 23, 25, 27, 32, 33, 41, 44, 69 coagulation disorders, 41 psychological conditions, 26, 27, 40 immunosuppressive medications, 25, 27, 64, 69 irradiation therapy to the head and neck region, 27, 56, 59, 64, 69 systemic bone diseases, 64, 69 history of intravenous bisphosphonates, 27, 56 osteoporosis, 25 and systemic corticosteroid therapy 33 were listed. Some studies specifically excluded pregnant and lactating individuals. 27, 33, 44, 47, 68 One study excluded individuals with incomplete skeletal growth. 28 Another study excluded patients with known allergies to the materials used. 41 Patients with alcohol or drug dependence were also excluded in a number of studies. 23, 25, 27, 33, 40, 41 The criteria applied to cigarette smoking varied between studies. In some studies, smokers were excluded 22, 32, 33, 40, 57, 59 ,67 whereas smokers were not excluded in other studies 35 or only excluded if subjects were heavy smokers. 23 A number of studies provided specific exclusion thresholds for cigarette smoking. A threshold of 10 cigarettes a day was commonly applied. 24, 42, 44, 47, 56, 60, 68 A threshold of 15 cigarettes a day was applied in one study 63 and 20 cigarettes a day was applied in another study. 62 Oral Factors. Untreated or uncontrolled periodontal disease was a common exclusion criteria. 22, [24] [25] [26] [27] [28] 31, 32, 51, 56, 60, 63, 65, 67, 68 In addition, untreated caries was an exclusion criteria in several studies. 22, 25, 32, 33 Site-Related Factors. For type 1 placement, acute infection at the site was a consistent exclusion criteria across the studies reviewed. [23] [24] [25] [26] [27] 32, 40, 41, 44, 51, 56, 57, 59, 60, 65, 67 A number of studies of Type 1 placement only included cases that presented with intact bone walls after tooth extraction [23] [24] [25] 38, 40, 41, 44, 51, 60, 63, 65, 67, 121 or cases with minimal loss of the facial bone wall. 27, 41, 56 Some studies stipulated a minimum distance from the midfacial gingival margin to crestal bone of 3 mm, 40 4 mm, 51 and 5 mm 26 or pre-extraction probing pockets of 3 mm or less. 25 A minimum distance from the gingival margin to the proximal bone of 4 to 6 mm was a requirement in one study 40 and 5 mm in another study. 51 One study included cases with varying degrees of damage to the facial bone wall. 48 Another study was designed specifically to include cases with complete loss of the facial bone wall. 64 There were a number of studies of type 1 placement that specifically excluded sites with thin tissue biotype, accepting cases with normal to thick tissue biotypes. 24, 32, 60, 62, 63 Two studies specifically included cases with thick tissue biotype only. 38, 67 In studies reporting on type 1 placement with connection of immediate provisional restorations, a high degree of stability of the implant was a strict requirement. 24, 25, 32, 38, 40, 44, 51, 57, 59, 60, [62] [63] [64] [65] 67, 69 The majority of these studies stated that they excluded subjects with bruxism or cases where it was determined that the posterior occlusion lacked stability. 24, 25, 40, 56, 57, 59, 60, 62, 63 Some studies specified a minimum height of 4 to 5 mm of bone apical to the extraction socket for stability of the implants to be achieved. 24, 38, 41, 56, 60, 67 An additional criterion was identified for flapless type 1 implant placement in conjunction with immediate provisional restoration. In five studies, cases with pre-extraction soft tissue contours that were in harmony with the surrounding teeth were included. 24, 32, 38, 60, 67 In contrast, one study of type 1 placement included sites in which the extracted teeth were periodontally involved and had pre-existing gingival recession. 66 In this study, CT grafts were placed in conjunction with coronally advanced flaps to correct the recession. Two studies, both of type 1 placement with immediate restoration, required that at least 2 mm of keratinized gingiva was present facially at the extraction site. 25, 62 DBBM PES = pink esthetic score; modPES = modified pink esthetic score; WES = white esthetic score; SES = subjective esthetic score; DBBM = deproteinized bovine bone mineral; GBR = guided bone regeneration.
For type 2 placement, there were no specific site related criteria imposed in studies in relation to tissue biotype, condition of bone walls, or presence of acute infection at the time of extraction, 35, 47, 68 except in one study which excluded cases where there was apical pathology at neighboring teeth. 68 Thin and thick biotypes for type 2 placement were specifically mentioned for inclusion in one study. 38 
DISCUSSION
Implant placement in postextraction sites has been a subject of great interest over the last 15 procedures. 15 The second systematic review in 2008 centered on clinical and esthetic outcomes. 133 In this third systematic review, the main focus was on esthetic outcomes for the various treatment options in postextraction implant placement based on objective esthetic criteria. The two esthetic parameters identified were (1) changes in the position of the peri-implant mucosa, and (2) two esthetic indices, predominantly the PES index. The studies included in this systematic review were found to have reported on single-tooth implant replacements adjacent to intact natural teeth. No papers dealing with multiple missing teeth were identified in the search. In the present systematic review, the search was limited to publications in the English language from two databases. It is possible that relevant articles were missed thereby undermining the internal validity of the systematic review.
The majority of included studies in this review were case series studies. The evidence from the pooled cases series studies should be evaluated with caution, as significant heterogeneity between studies was observed. This was most likely due to differences in study populations, surgical and grafting techniques, and loading protocols used. Grouping of studies according to the different clinical techniques used provides an insight into trends, but should not be regarded as strong evidence.
Concerning positional changes of the midfacial peri-implant mucosa, there were two RCTs and one cohort study, which compared outcomes following different implant placement timings. These studies showed no differences between immediate (type 1) and early implant placement (type 2). The majority of included studies were case series studies, which predominantly reported on type 1 placement.
For changes in the midfacial mucosal position, the studies were heterogeneous and showed a wide variation in results. Although case series studies on type 2 placement appeared more homogenous, the analysis was based on a small number of studies (3) and should be interpreted with care. Stratification of the type 1 placement studies according to similarity in treatment protocols revealed more homogenous results in relation to changes in the midfacial mucosal level when flapless implant placement was combined with bone graft, CT graft, and connection of an immediate provisional crown. It should be noted that this finding is based on only three case series studies and should be interpreted with caution. For change in position of the papillae, the results between studies were highly variable. No trend was observed for differences in outcomes when studies were stratified according to surgical approach (flap vs flapless placement) and use of immediate provisional crowns.
For outcomes based on esthetic indices, most studies used the PES index. One RCT and two cohort studies provided data on different placement timings. The RCT compared type 1 and type 4 placements; however, the follow-up time of 4 months from provisional prosthesis insertion was too short to make any meaningful conclusions. One cohort study provided evidence that PES was significantly higher for type 1 placement compared to sites that had received block bone grafts to correct significant ridge defects. Similar to the available data for change in peri-implant mucosal position, the majority of studies using esthetic indices were case series studies that predominantly reported on type 1 placement. The studies showed a high degree of heterogeneity.
In summary, the evidence to evaluate the esthetic outcomes with postextraction implants are based on a limited number of randomized and cohort studies, with the vast majority of evidence provided by cross-sectional and case series studies. Nevertheless, well-conducted cross-sectional and case series studies can provide meaningful data when interpreted carefully. Currently, the evidence suggests that acceptable esthetic outcomes can be achieved with type 1 and early implant placement (type 2 and type 3). For positional change of the peri-implant mucosa, it may be anticipated that on average, a small degree of recession of the midfacial mucosa of about 0.5 mm will occur following implant placement. When comparing treatment options, the outcomes for type 1 placement showed more variation compared to type 2 and 3 placements. There was also a higher frequency of recession of > 1 mm of the midfacial mucosa for type 1 placement compared to type 2 and 3 placements.
The analysis clearly shows the variability and potential risk for mucosal recession in the range of 20% to 30%, if no inclusion criteria are used for immediate implants (type 1 placement). This is in accordance with the findings of the previous ITI Consensus Conference in which the potential risk factors for recession with type 1 placement were identified as pre-existing defects of the facial bone, thin facial bone, thin soft tissue biotype, and facial malposition of the implant. 134 To reduce the risk of mucosal recession, the majority of studies published after 2008 on type 1 placement have imposed strict case selection criteria by only including sites with intact facial bone and medium to thick tissue biotype. It has also been recognized that ongoing resorption and modeling of the facial bone takes place following implant placement, with changes most notable after type 1 placement. To reduce the risk of recession of the mucosa with type 1 placement, clinicians have applied treatment strategies to counteract these changes, including the concomitant use of CT grafts, low-substitution bone fillers in the peri-implant defects, and flapless surgery.
For papillae, the evidence shows that recession of the tooth-implant papillae of 0.5 to 1 mm may be anticipated following implant surgery irrespective of the timing of placement. Interestingly, there was little evidence to support flapless surgery or connection of an immediate provisional crown as a means to reduce papillary recession with type 1 placement.
The predominant index used to report on esthetic outcomes was the PES index. The esthetic outcomes for type 1 and type 2 placements were similar although significant heterogeneity between studies was noted. Mean scores reported were in a narrow range of 9.5 to 11.5. The strength of the PES is that it has been shown to be consistently reproducible in a number of studies [135] [136] [137] and provides a measure of symmetry of the peri-implant mucosa with the adjacent natural teeth. The PES, however, is a summation of seven soft tissuerelated factors assigned scores on an ordinal scale. The weakness of the PES is that each factor is assumed to carry equal weight in contributing to the overall score; however, this has not been demonstrated in the literature. Indeed it may be argued that, for example, midfacial mucosal recession of 1 to 2 mm (assigned a score of 1) has more impact esthetically then the equivalent score of 1 for color or consistency of the peri-implant mucosa. The PES is therefore not sensitive to linear changes in soft tissue levels. A clinically more meaningful application of PES is to rank esthetic outcomes as shown in Table 10 . The proportion of excellent, acceptable, and poor outcomes may provide the clinician with greater insight into the esthetic success of the clinical techniques under scrutiny rather than comparing the mean PES. Several studies reported on outcomes relating to the papillae using the Papilla Index of Jemt. 138 This index, however, was originally designed to monitor changes in the degree of soft tissue fill within the tooth-implant embrasure spaces after delivery of the definitive crowns. As it is neither a measure of symmetry nor a record of linear soft tissue changes, it is unsuitable as an esthetic index.
A critical determinant for stable esthetic outcomes long-term is the integrity and stability of the facial bone wall. Recently, 3D radiology predominantly using CBCT has provided a noninvasive method to assess the status of the facial bone. This technology does have limitations, as intact but thin facial bone may not always be detectable on the reformatted images. 139 However the strong correlation between the radiographic presence of the facial bone and a more coronal location of the midfacial mucosa 20 suggests that the thickness of the facial bone is an important outcome variable. The study of Buser and coworkers that reported on the dimensions of the facial peri-implant bone on CBCT images is worthy of particular note. 21, 35 The facial bone walls that were reconstructed with a combination of autogenous bone chips and DBBM particles were largely intact at an average of 7 years following implant placement. Of clinical significance was the stability of the position of the peri-implant mucosa throughout the observation period, which, it may be speculated, could be due to the underlying thick facial bone. A recent follow-up of a previous study 47 by the same group reported that all 20 implant sites had a detectable facial bone wall averaging 1.9 mm in thickness after 6 years. The timing of implant placement may also be an important consideration. The two CBCT studies of type 1 placement reported diminished bone thickness and increased mucosal recession even when the peri-implant defects were grafted with either autogenous bone or DBBM. 20, 37 It may be speculated that the thin facial bone at the crestal region continued to resorb even in the presence of a bone graft, a phenomenon previously observed in a RCT with surgical reentry. 36 It is hypothesized that DBBM particles have only low substitution characteristics if the particles are embedded in bone. As shown in a recent preclinical study, DBBM particles embedded in soft tissue showed signs of resorption. 141 More research is needed to better understand these aspects. It also must be noted that the current evidence with CBCT data is limited, since some studies are based on small numbers of patients with rather short observation periods. It is anticipated that future studies using 3D radiologic imaging of the facial bone wall will provide further evidence for the relationship between the presence or absence of the facial bone, the thickness of the facial bone, the position of the bone crest, and the long-term stability of the peri-implant mucosa.
CONCLUSIONS
Six RCTs and six cohort studies provided high level evidence for the assessment of esthetic outcomes with postextraction implants. The majority of included studies were cross-sectional and case series studies that allowed trends in esthetic outcomes with various surgical approaches to be explored.
Acceptable esthetic outcomes, determined by esthetic indices and positional changes of the periimplant mucosa, may be achieved for single-tooth implants placed following tooth extraction.
Immediate (type 1) implant placement is associated with a greater variability in outcomes and a higher frequency of recession of > 1 mm of the midfacial mucosa (8 studies; range 9% to 41% and median 26% of sites; 1 to 3 years after placement) compared to early (type 2 and type 3) implant placement (two studies; no sites with recession > 1 mm).
In two retrospective studies of immediate (type 1) implant placement with bone graft, the facial bone wall was not detectable on cone beam CT in 36% and 57% of sites. These sites had more recession of the midfacial mucosa compared to sites with detectable facial bone.
Two studies of early implant placement (type 2 and 3) combined with simultaneous bone augmentation with GBR (contour augmentation) demonstrated a high frequency (above 90%) of facial bone wall visible on CBCT.
Further research is required to determine the effect of different surgical and loading protocols on esthetic outcomes.
Integrity of the facial bone may be an important factor for long-term stability of esthetic outcomes. Further research is needed to investigate the most suitable biomaterials to reconstruct the facial bone and the relationship between mucosal stability long-term and the presence or absence of the facial bone, the thickness of the facial bone, and the position of the facial bone crest.
